Risk factors for neutropenia and febrile neutropenia following prophylactic pegfilgrastim

Medicine and Dentistry

• Neutropenia 100%
• Patient 58%
• Platelet 41%
• Prophylaxis 33%
• Age 25%
• Chemotherapy 25%
• Radiation Therapy 25%
• Diffuse Large B-Cell Lymphoma 25%
• Breast Cancer 16%
• Low Platelet Count 16%
• Inpatient 8%
• Laboratory 8%
• Combination Therapy 8%
• Absence 8%
• Cancer Types 8%
• Logistic Regression Analysis 8%
• Side Effect 8%
• Univariate Analysis 8%
• Cancer Staging 8%
• Patient with Cancer 8%
• Incidence 8%
• Electronic Patient Record 8%
• Subgroup Analysis 8%
• Granulocyte Colony Stimulating Factor 8%
• Observational Study 8%